New Journey Health Hits Day Low of CNY 2.29 Amid Price Pressure

New Journey Health Technology Group Co., Ltd. experienced a significant decline today, with the stock dropping by 6.91% and reaching an intraday low of CNY 2.29. This performance stands in contrast to the China Shanghai Composite, which fell by only 1.24% on the same day. Over the past week, New Journey has seen a more pronounced downturn, with a total decline of 8.4%, while its one-month performance reflects a decrease of 3.78%. The company's financial metrics indicate ongoing challenges, including a high debt-to-equity ratio of 101.72% and a return on equity of just 1.27%. Despite a modest annual sales growth rate of 2.71%, the company has faced operating losses, contributing to a year-to-date performance of 7.51%. However, this is overshadowed by a one-year decline of 16.42%, highlighting a consistent underperformance against the benchmark. As a mid-cap player in the Pharmaceuticals & Biotechnology sector, New Journey's market capitalization stands at CNY 7,718 million. The stock's price-to-earnings ratio is notably high at 114.00, further emphasizing the financial pressures the company is currently navigating.